Form 4: Avalo Therapeutics Director Acquires Shares Through Restricted Stock Unit Vesting

Director Aaron Kantoff acquired 3,167 shares of Avalo Therapeutics common stock on March 28, 2025, through the vesting of restricted stock units.

Summary

• On March 28, 2025, Aaron Kantoff, a director of Avalo Therapeutics, acquired 3,167 shares of common stock.
• This acquisition resulted from the vesting of restricted stock units (RSUs).
• The RSUs convert into common stock on a one-for-one basis.
• Kantoff was initially granted 9,500 RSUs on August 13, 2024, which vest in three equal installments on March 28, 2025, March 28, 2026, and March 28, 2027, contingent upon continued service.
• Following the transaction, Kantoff directly owns 6,333 derivative securities.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing reflects a routine transaction related to executive compensation.

Positives

• The vesting of RSUs indicates a continued alignment of the director's interests with those of the shareholders.
• The director's continued service is required for the vesting of the remaining RSUs, incentivizing long-term commitment.

Future Outlook

The director will continue to vest in the remaining restricted stock units on March 28, 2026, and March 28, 2027, subject to continued service.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. This filing indicates a standard vesting schedule for previously granted equity compensation.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's long-term performance.

Next Steps

• The director will vest in the remaining RSUs on the scheduled vesting dates, contingent upon continued service.
• The company will likely file additional Form 4s upon future vesting events.

Key Dates

Keywords

Avalo Therapeutics, Director, Aaron Kantoff, Form 4, Beneficial Ownership, Restricted Stock Units, RSU, Vesting, AVTX, Shares